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PeptidomimeticWnt4 and β-catenin are both required for nephrogenesis, but studies using TCF-reporter mice suggest that
canonical Wnt signaling is not activated in metanephric mesenchyme (MM) during its conversion to the
epithelia of the nephron. To better deﬁne the role of Wnt signaling, we treated rat metanephric mesenchymal
progenitors directly with recombinant Wnt proteins. These studies revealed that Wnt4 protein, which is
required for nephron formation, induces tubule formation and differentiation markers Lim1 and E-cadherin in
MM cells, but does not activate a TCF reporter or up regulate expression of canonical Wnt target gene Axin-2
and has little effect on the stabilization of β-catenin or phosphorylation of disheveled-2. Furthermore, Wnt4
causes membrane localization of ZO-1 and occludin in tight junctions. To directly examine the role of β-
catenin/TCF-dependent transcription, we developed synthetic cell-permeable analogs of β-catenin's helix C,
which is required for transcriptional activation, in efforts to speciﬁcally inhibit canonical Wnt signaling. One
inhibitor blocked TCF-dependent transcription and induced degradation of β-catenin but did not affect tubule
formation and stimulated the expression of Lim1 and E-cadherin. Since a canonical mechanism appears not to
be operative in tubule formation, we assessed the involvement of the non-canonical Ca2+-dependent
pathway. Treatment of MM cells with Wnt4 induced an inﬂux of Ca2+ and caused phosphorylation of CaMKII.
Moreover, Ionomycin, a Ca2+-dependent pathway activator, stimulated tubule formation. These results
demonstrate that the canonical Wnt pathway is not responsible for mesenchymal–epithelial transition (MET)
in nephron formation and suggest that the non-canonical calcium/Wnt pathway mediates Wnt4-induced
tubulogenesis in the kidney.al Biology Laboratory, Building
D, 21702-1201, USA. Fax: +1
oni).
Inc.Published by Elsevier Inc.Introduction
Reciprocal interactions between the metanephric mesenchyme
(MM) and ureteric bud (UB) are required for nephron formation in
kidney development. The UB induces MM to undergo epithelial
conversion to form the nephron through a series of morphogenetic
transformations, including condensation, pretubular aggregation, and
mesenchymal–epithelial transition (MET) (Dressler, 2006). Multiple
inductive signaling ligands have been elucidated in this process,
including Wnts (Kispert et al., 1998), ﬁbroblast growth factors (FGFs)
(Perantoni et al., 1995), transforming growth factor-β2 (TGF-β2)
(Plisov et al., 2001) and leukemia inhibitory factor (LIF) (Barasch etal., 1999; Plisov et al., 2001), using an explant culture system with
isolated MMs. These studies imply the existence of progenitor cells in
MM rudiments with the retained capacity to produce the epithelia
that comprise the various segments of the nephron (Karavanova et al.,
1996; Osafune et al., 2006; Perantoni et al., 1995).
Wnt/β-catenin signaling is essential for both normal development
and tumorigenesis (Koesters and von Knebel Doeberitz, 2003; Logan
and Nusse, 2004; Smalley and Dale, 1999). In the canonical Wnt/β-
catenin signaling pathway, engagement of a Wnt receptor Frizzled
leads to stabilization of β-catenin, which is then translocated into the
nucleus to initiate gene expression through interaction with a
member of the TCF transcription factor family. Alternatively, two
major TCF-independent Wnt signaling mechanisms have also been
described: a Ca2+-releasing pathway (Kohn and Moon, 2005; Kuhl
et al., 2000b) that is activated by Wnt-stimulated G proteins and the
planar cell polarity (PCP) pathway that involves Wnt-activated c-Jun
N-terminal kinase (Katoh, 2005; Yamanaka et al., 2002).
During kidney development, the requirement forWnt9b andWnt4
in nephrogenesis has been demonstrated using genetically modiﬁed
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pretubular aggregates and is essential for normal conversion of MM to
the epithelia of the nephron (Carroll et al., 2005; Stark et al., 1994).
Wnt9b, which is expressed in the UB, functions upstream of Wnt4,
and its loss could be rescued with Wnt1, a putative canonical Wnt
signaling activator (Carroll et al., 2005). In addition, removal of β-
catenin in MM showed reduced nephron formation (Park et al., 2007).
These results suggest that canonical Wnt/β-catenin is involved in
tubule formation in MM; however, constitutive expression of
stabilized β-catenin cannot induceMET in culturedMMs or transgenic
mice (Park et al., 2007; Schmidt-Ott et al., 2007). Furthermore, studies
with β-catenin-activated transgenic reporter (BAT-gal) mice or TCF-
driven β-gal reporter mice revealed that β-catenin-dependent
transactivation occurs in the branching UB but not in the surrounding
MM or its derivatives (Iglesias et al., 2007; Maretto et al., 2003),
suggesting that β-catenin/TCF-dependent transcriptional activation
may not be required for mesenchymal cell differentiation. Although
the Wnt/β-catenin pathway has been implicated as a regulator of
epithelial formation, the precise mechanism(s) by which Wnt4
mediates its cellular effects in nephrogenesis remains unclear.
In this study, we conﬁrm that BATlacZ transgenic mice have strong
β-gal activity in the UB but not in MM cells. We also report that Wnt4
does not activate canonical signaling in MM but rather induces MET
through a non-canonical Ca2+-dependent pathway.
Materials and methods
Reagents and antibodies
Ionomycin, A23187 and BAPTA-AM were purchased from BIOMOL
(Plymouth Meeting, PA, USA). Wnt4, Wnt9b and Wnt3a recombinant
proteins were from R&D systems (Minneapolis, MN, USA). Antibodies
were obtained as follows: for β-catenin (#9562), Dvl2 (#3224),
phospho-CaMKII (#3361) and pan-CaMKII (#4436)—from Cell Signaling
Technology (Beverly, MA, USA); for ZO-1 (#339100), Occludin
(#711500), rabbit Alexa Fluor 488 and mouse Alexa Fluor 555-
conjugated secondary antibodies—from Invitrogen (Carlsbad, CA, USA);
for β-actin (A5441)—from Sigma (St. Louis, MO, USA); for E-cadherin
(#610181)—from BD Biosciences (San Jose, CA, USA).
Animals and Metanephric mesenchymes
Generation and conﬁrmation of BATlacZ transgenic mice as well as
X-gal staining were previously described (Nakaya et al., 2005). All
animal procedureswere performed following the guidelines fromNCI-
Frederick Animal Care and Use Committee. NCI-Frederick is accredited
by AAALAC International and follows the Public Health Service Policy
for the Care and Use of Laboratory Animals. Animal care was provided
in accordance with the procedures outlined in the “Guide for Care and
Use of LaboratoryAnimals” (National Research Council, 1996;National
Academy Press, Washington, D.C.). Metanephric mesenchymes dis-
sected away from T-shaped ureteric buds were prepared from E13.5
rat embryos and cultured as described previously (Perantoni et al.,
1991). Cultured mesenchymes were treated with 50 ng/ml human
FGF2 and 10 ng/ml human TGF-α (R&D systems). Wnt4-soaked beads
were prepared with Afﬁ-gel Blue Gel (BioRad, Hercules, CA, USA).
Beadswere rinsed in PBS several times and soaked in 100 ng/mlmouse
Wnt4 recombinant protein (R&D system), or 100 ng/ml BSA-PBS (for
control) solution overnight at 4 °C. Prepared beads were implanted
into the MM rudiments. Wnt3a conditionedmedium (Wnt3aCM)was
prepared as described (Willert et al., 2003).
Tissues and primary MM cell cultures
Metanephric mesenchymes were enzymatically separated from
the ureteric buds and cultured on Matrigel-coated BD-Biocoat 10-cmdishes (BD Biosciences) in serum-free Ham's F12:DMEM 1:1 (Gibco,
BRL) medium with supplements as described (Perantoni et al., 1991)
and with the addition of 10 ng/ml human TGF-α and 50 ng/ml human
FGF2. Tissues were grown for 10 days, resulting in a 50–100 fold
increase in cell numbers. Cells were removed from plates with
trypsin–EDTA solution (Gibco-Invitrogen).
Whole mount in situ hybridization (WISH)
WISH was performed essentially as described previously (Pizard
et al., 2004), except that BM purple (Roche Diagnostics GmbH,
Mannheim, Germany) was used as the chromogenic substrate. In
short, plasmids with cDNAs encoding the Lim1 (Karavanova et al.,
1996) gene were linearized at the 5′-end of the inserts and used to
generate antisense probes corresponding to the coding sequences
with a transcription kit and DIG-labeled dNTPs (Roche). Probes were
precipitated and tested on agarose gels for integrity. Prior to the in situ
hybridization procedure, the tissues or explants were ﬁxed overnight
with 4% paraformaldehyde in PBS after 3–6 days culture, and then
tissues were pre-hybridized for 1 h at 70 °C in hybridization buffer
(50% formamide, 5× SSC, 50 μg/ml heparin, 500 μg/ml tRNA, 0.1%
Tween20, and 9.0 mM citric acid) and incubated with 50 ng of probe
overnight at 70 °C in hybridization buffer. The samples were washed
with optimized wash buffer. The samples were placed for 3 h in
blocking solution at room temperature and then incubated overnight
at 4 °C with an alkaline phosphatase-coupled anti-digoxigenin
antibody (Roche) at a 1/1000 dilution in blocking buffer. Finally, the
samples were washed, and stained with BM purple (Roche). The
reaction was stopped in 4% PFA in PBST.
Semi-quantitative RT-PCR
Total RNA was puriﬁed using TRIzol reagent (Invitrogen), and
RNase-Free DNase Set (Qiagen, Valencia, CA, USA) was used to digest
genomic DNA during RNA puriﬁcation. For RT-PCR, random hexamer
primers were used to generate cDNA from total RNA. Gene-speciﬁc
primers were then used to amplify PCR fragments. RT reactions were
performed with a Superscript III RT kit according to manufacturer's
instructions (Invitrogen). PCR reactions were performed using a PCR
enzymemix (Roche) with primers. Incubation conditions consisted of
35 cycles (30 s at 94 °C, 30 s at 55–60 °C (depending upon primer
optimal annealing temperatures) and 30 s at 72 °C). Primer
sequences, annealing temperatures, and cycle parameters are shown
in Supplementary Table 1.
Immunoblot analysis
After treatments, cells were washed with PBS, pH7.4, scraped with
Laemmli reducing sample buffer, and resolved in 4–20% Tris-glycine
gels (Invitrogen). Proteins were electrotransfered to PVDF mem-
branes (Bio-Rad, Hercules, CA, USA). Membranes were blocked with
5% nonfat dry milk in TBST and incubated overnight at 4 °C with
primary antibodies. Membranes were washed with TBST, followed
with species-speciﬁc HRP-conjugated secondary antibodies. Bound
antibodies were visualized using the SuperSignal West Pico Chemi-
luminescent Substrate system (ThermoFisher Scientiﬁc, Rockford, IL)
according to manufacturer's instructions.
Electroporation and reporter gene assay
Primary MM cells were transfected with the Amaxa Nucleofector
96-well Shuttle System (Lonza Group Ltd, Basel, Switzerland). Brieﬂy,
1×106 cells per transfection were resuspended in 20 μl of 96-well
Nucleofector solutions. TOPﬂash luciferase plasmid (1 μg) and 0.1 μg
pRL-TK-renilla plasmids (Promega, Madison, WI, USA) were mixed
with cell suspensions and transferred to the well of a 96-well
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manufacturer's instructions using program DN-100. Twenty-four hours
after transfection, cells were treated with various factors for an
additional 24 h of incubation. Cells were lysed and assayed for reporter
activity using a Dual luciferase assay system (Promega) and a
Microlumat Plus Luminometer (Berthold Technologies, Oak Ridge, TN).
Immunocytochemistry
Primary MM cells were cultured on 3-cm cover slip dishes and
treated as indicated. Cells were washed with PBS, ﬁxed in ice-cold
methanol for 10 min, and washed with PBS for 10 min. The cells were
blocked for 1 h at room temperature with 10% goat serum in PBS, and
incubated with ZO-1 (1:50) or occludin (1:50) antibodies for 1 h. The
cells were then washedwith 1% goat serum in PBS and incubated with
Alexa Fluor 488-conjugated secondary antibody for 1 h. The cells were
treated with DAPI, mounted on slides with Vectashield (Vector
laboratories, Inc., Burlingame, CA, USA), and visualized using a Zeiss
LSM510 META confocal microscope (Carl Zeiss, Jena, Germany) at
400× magniﬁcation. Confocal images were captured and analyzed by
the LSM image Browzer program (Zeiss).
Ca2+ inﬂux
Calcium indicator Fluo-4 NW (Invitrogen) was used for intracel-
lular calcium inﬂux detection following manufacturer's instructions.
Primary MM cells were cultured at 50,000 cells per well in black,
clear-bottom poly-Lysine coated 96 well plate (BD Biosciences).
Calcium assays were performed in a NOVOstar multifunctional plate
leader (BMG LABTECH Gmbh, Offenburg, Germany). The cells were
treated with different concentrations of Wnt4 by using a NOVOstar
pipettor. Samples were added at 10 s and readings were taken up to
4 min at 1 s intervals. The ﬂuorescence intensity mode used included
a 485/10 excitation ﬁlter and a 520/10 emission ﬁlter. Background
ﬂuorescence for each well was measured every 1 s for 4 min without
addition of ligand, and the average background was subtracted from
each value. Data are representative of 3–5 independent experiments.
Peptide synthesis
The peptides were synthesized on a 433A Peptide Synthesizer
(Applied Biosystems) using Fmoc chemistry. The peptideswere cleaved
from the resin and deprotected with a mixture of 90.0% (v/v)
triﬂuoroacetic acid (TFA) with 2.5% water, 2.5% triisopropyl-silane,
and 5% thioanisole. The resin anddeprotectionmixturewere pre-chilled
to−5 °Cand reacted for 15 min at−5 °Cwith stirring. The reactionwas
allowed to continue at room temperature for 1.75 h. The resin was
ﬁltered off and theproductwas precipitatedwith cold diethyl ether. The
resinwaswashedwithneat TFA. Peptide suspended indiethyl etherwas
centrifuged at −20 °C and the precipitate was washed with diethyl
ether four more times and left to dry in a vacuum overnight. The dried
crude peptide was dissolved in DMSO and puriﬁed on a preparative
(25 mm×250 mm) Atlantis C18 reverse phase column (Agilent
Technologies) in a 90 minute gradient of 0.1% (v/v) triﬂuoroacetic acid
in water and 0.1% triﬂuoroacetic acid in acetonitrile, with a 10 ml/min
ﬂow rate. The fractions containing peptides were analyzed on Agilent
1100 LC/MS spectrometer with the use of a Zorbax 300SB-C3 Poroshell
column and a gradient of 5% acetic acid in water and acetonitrile.
Fractions that were more than 95% pure were combined and freeze
dried. Retro-inverso peptidemade of all-D amino acidswas synthesized
using essentially the same protocol, except that palmitic acid had to be
introduced in the side chain. Resin preloadedwithα-Fmoc-ε-palmitoyl-
D-Lys was prepared as described (Remsberg et al., 2007). Purity (N95%)
and structure of all peptides were conﬁrmed by mass spectrometry
using Agilent C18 reversed-phase columns (4.6×150 mm) and an
Agilent 1100 LC/MC system.Statistical analysis
Data were evaluated for statistical signiﬁcance by analysis using
Student t-test. Statistical differences were considered signiﬁcant if
pb0.05* or pb0.01**. All experiments were performed independently
at least three times, and the data presented are from a representative
experiment. The results are presented as mean±SD (error bars).
Results
Canonical Wnt/β-catenin signaling is not detected in MM from a
reporter mouse
To assess the role of Wnt/β-catenin signaling in nephron
formation, we examined the LacZ expression pattern in the kidneys
of BATLacZ reporter transgenic mice (Nakaya et al., 2005). As shown
in Fig. 1A, strong β-gal staining was observed in the UB but not in MM.
To conﬁrm that the reporter is inducible in MM, we assessed
expression in isolated MM from a BATLacZ reporter transgenic
mouse treated with the GSK3 inhibitor BIO or LiCl. As shown, both
established activators of canonical Wnt signaling can induce β-
galactosidase activity in explanted MMs from BATLacZ reporter mice
(Supplementary Fig. 1). These results suggest that β-catenin/TCF-
dependent transactivation is not required for conversion of MM to
nephronic epithelia, although it may still be involved in progenitor
proliferation or maintenance (Schmidt-Ott et al., 2007).
Since Wnt4 is required for nephronic differentiation in MM
(Kispert et al., 1998; Stark et al., 1994), we ﬁrst addressed whether
puriﬁed recombinant protein can induce tubule formation in explant
culture. For this, primary MMs were treated with Wnt4-soaked beads
(100 ng/ml). As shown in Fig. 1B, tubule formation and expression of
tubular epithelial marker Lim1were observed in cultures treated with
Wnt4 but not in control cultures. These results conﬁrm the biological
activity of the commercially produced recombinant protein and
further demonstrate that soluble Wnt4 protein can induce MET.
Primary MM cells retain the ability to differentiate
Studies on signal transduction in metanephric mesenchymal cells
have been signiﬁcantly hindered by the limited number of mesenchy-
mal cells that can be obtained from each embryonic metanephros. To
overcome this handicap, we cultured primary metanephric mesench-
ymes on Matrigel in serum-free medium with TGFα and Fgf2 for
10 days. This allowedus to expand 30–40 isolatedMMs into 4–8 million
cells without obvious loss of responsiveness to tubule induction.
In order to assess the stability of expression of several develop-
mentally relevant genes in cultured cells, we isolated RNA from
uncultured MMs and 10-day cultures of MM cells explanted to
Matrigel-coated dishes and performed semi-quantitative RT-PCR for
expression. All of the genes examined were expressed in both
uncultured (Fig. 2A, lane 1) and cultured (Fig. 2A, lane 2) cells. The
genes included Six1, Six2, Cited1, Wt1, Osr1, Eya1, Sall1, Gdnf, Pax2,
Hoxa11, Lim-1 and E-Cadherin. Only epithelial markers Lim1 and E-
cadherin were not expressed and Sall1 and Pax2 were somewhat
reduced in cultured cells. These results suggest that the expansion of
these cells in culture does not dramatically alter the expression of
genes associated with progenitor differentiation, nor is there an
obvious selection of a sub population within the tissue. Next, the
suitability for use in differentiation studies was conﬁrmed by
cocultivation with embryonic spinal cord (SC) on type IV collagen-
coated ﬁlter. As shown in Fig. 2B, cultured cells, which were co-
cultivated with SC, formed tubules which expressed epithelial marker
Lim1. Furthermore, treatment of cells with Wnt4 protein induced the
expression of epithelial markers Lim1 and E-cadherin, the condensa-
tion markers Pax2 and Pax8, and the tight-junction markers ZO-1 and
occludin (Fig. 2C). In addition, co-localization of junctional adhesion
Fig. 1. TCF transactivation in the embryonic kidney of BATlacZ reporter mice occurs in
the UB but not MM while Wnt4 induces tubule formation in MM. A. Expression of
BATLacZ reporter in vivo in transgenic mouse kidney. Strong β-gal staining was
observed only in the UB (white arrow) and not inMM cap cells (black arrow) and newly
formed tubules (black arrow) at E11.5 or E14.5. B. Tubule formation by recombinant
Wnt4 in rat MM. Isolated rat MMs at 13.5 days were cultured on collagen type IV-
coated ﬁlters ﬂoating on culture medium with FGF2 (50 ng/ml) and TGF-α (10 ng/ml)
and treated with Wnt4 recombinant protein soaked beads (100 ng/ml) for 3 days.
Tissues were ﬁxed and analyzed by WISH with a Lim1 riboprobe as described in the
Materials and methods section.
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tive of epithelial cell tight-junction formation, was observed with
Wnt4 treatment (Fig. 2D). These results conﬁrm that cultured primary
MM cells have retained the ability to undergo epithelial morphogen-
esis and form tubules.
Wnt4 fails to activate TCF-dependent transcription
To investigate the effect ofWnt4protein on canonicalWnt signaling, a
TOPﬂash reporter construct was transfected into MM cells. As shown in
Fig. 3A, Wnt4 treatment (100 ng/ml) did not affect TCF/LEF dependent
transactivation, whereas Wnt3a induced a 4–6 fold increase in reporter
activity in these cells.Moreover, the canonicalWnt target gene Axin2was
inducedbyWnt3a treatmentbutnot byWnt4protein (Fig. 3B), indicating
that Wnt4 did not stimulate TCF/LEF transactivation in this system.
Wnt9b showed amodest induction of reporter activation, suggesting thatit may also function through a canonical Wnt mechanism, although we
did not pursue this further. We then examined the effect of Wnt4 on β-
catenin protein stabilization and disheveled-2 (Dvl2) phosphorylation
prior to differentiation. Dvl2, which undergoes phosphorylation in
response to Wnt signals that stabilize β-catenin (Rothbacher et al.,
2000), andβ-cateninwere analyzed by immunoblotting (Figs. 3C andD).
Wnt4 recombinant protein dramatically enhanced the level of E-cadherin
but did not alter the levels of total β-catenin at 24 h or Dvl2
phosphorylation (Fig. 3C), while Wnt3a induced the accumulation of
both β-catenin and Dvl2 phosphorylation within 5 min of treatment
(Fig. 3D). A detectable increase in β-catenin at 48 and 72 h post-Wnt4
treatment was concomitant with the increased expression of E-cadherin
andmay result from a sequestration of β-catenin tomembrane adherent
complexes. Taken together, these results suggest that Wnt4 induces
differentiation in a β-catenin/TCF-independent manner.
Development of synthetic inhibitors of β-catenin-mediated
transcriptional activity
Recent reports documenting the crystal structure of β-catenin
have revealed novel structural details that may permit the separation
and differential regulation of adhesion activity from transcription
functions (Xing et al., 2008). A C-terminal region called helix C, which
represents a predicted 13th Armadillo repeat and encompasses amino
acid residues 667–683, has now been identiﬁed as an essential motif
for transcription but not adhesion (Xing et al., 2008). We hypothe-
sized therefore that synthetic analogs of the helix could function as
dominant-negative inhibitors of β-catenin transcriptional activity.
Based on the X-ray structure of full-length β-catenin, we designed
lipopeptide analogs of the C-terminal helix (Figs. 4A and B). Lipidation
of the peptides was used to enhance cell penetration and structure
stabilization of the antagonist, as it was shown previously to
dramatically improve the biological activity of protein fragments
(Remsberg et al., 2007; Timofeeva et al., 2007). Helix C is also believed
to interact with β-catenin-binding proteins Chibby and ICAT, which
are involved in inhibiting transcriptional activation ofWnt-responsive
genes. Structural analysis of β-catenin suggests that helix C forms
extensive interactions with the last armadillo repeat. Leu674, Leu678
and Leu682 ﬁt into a hydrophobic groove formed by the second and
third helices of armadillo repeat 12 (Xing et al., 2008). Lys681 is likely
to form an ion pair with Glu664, while Arg684 forms a hydrogen bond
with Ser646. We used these interactions for generation of peptides
that are likely to compete with the native helix C in the assembly of
the protein. Since negative charges of the peptides impede cell
membrane penetration, we replaced Glu677 with Gln since, according
to structural data, this residue is not involved in any intra-molecular
interactions (CT-HC-3, Fig. 4B). To generate metabolically stable
versions of peptides, we prepared retro-inverso derivatives con-
structed from all-D amino acids (CT-HC-5). An analysis of the three
CT-HC peptides revealed signiﬁcant cytotoxicity on primary MM cells
following treatments with CT-HC-3 and -5 (Fig. 4C). We therefore
selected CT-HC-1 for subsequent experiments. Concurrently, we
designed peptides for targeting the intracellular domain of EpCAM
(Fig. 4B), which interacts with β-catenin and Lef1 to form a nuclear
complex that regulates β-catenin-dependent transcription (Maetzel
et al., 2009). These peptides not only failed to inhibit both BIO- and
Wnt3aCM-induced transcriptional activity (Supplementary Fig. 2) but
also showed no cell toxicity (Figs. 4C and G), so they were used as
negative controls in subsequent studies. On the other hand, CT-HC-1
completely blocked BIO- and Wnt3aCM-induced transcription in
culturedMM cells (Figs. 4D and E). Similar results were obtained with
incubations for 1, 24, and 48 h (only the 24-hr period shown)
following the single addition of CT-HC-1. Cells were also evaluated for
levels of total β-catenin. In these studies, β-catenin was degraded
within 3 h of treatment with CT-HC-1 (Figs. 4F and G), and levels had
not recovered after 24 h (Fig. 4C). Since this suggested that the effect
Fig. 2. Cultured primary MM cells respond to inductive cues. A. Primary MM cells express MM progenitor markers. MM markers were detected by semi-quantitative RT-PCR with
indicated primers in E13.5 rat MM (lane 1), 10-day cultured primary MM cells (lane 2) and no RT (lane 3). B. Spinal cord induces tubule formation in primary MM cells. Expanded
primaryMM cells were trypsinized and then co-cultivated with embryonic spinal cord on collagen type IV-treated ﬁlters. After 6 days, tissues were ﬁxedwith 4% PFA and assessed by
WISH with a Lim1 riboprobe. C. Wnt4 induces expression of epithelial markers. Expanded primary MM cells were cultured on 6-well plates and treated with recombinant Wnt4
protein (100 ng/ml) for 24 h, and then harvested with TRIZOL. cDNAs were synthesized and examined by semi-quantitative RT-PCR for Lim1, E-cadherin, ZO-1, Occludin, Pax2, Pax8
and GAPDH. D.Wnt4 induces tight-junction formation. PrimaryMM cells were cultured on 3-cm coverslips for 24 h, and then treated with recombinantWnt4 protein (100 ng/ml) for
3 h. After ﬁxation, cells were co-incubated with anti-Occludin (green) and anti-ZO-1 antibodies (red). Co-localization of ZO-1/occludin was determined by immunoﬂuorescence
confocal microscopy. Tight-junction formation was characterized by co-localization of Occludin and ZO-1 (yellow staining).
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β-catenin, cells were also treated with proteasomal inhibitor MG132.
As observed, β-catenin levels were stabilized even in CT-HC-1-treated
cells, demonstrating that peptide activity is likely due to the
accelerated degradation of its target (Fig. 4F).
Targeted inhibition of β-catenin/TCF transactivation fails to inhibit MM
differentiation
To determine if the loss of β-catenin affects differentiation, MM
cells were co-cultivated with inductor, embryonic spinal cord, andtreated with CT-HC-1 (Fig. 4H). In these cultures, tubule formation
was unaffected. This ﬁnding was supported by semi-quantitative RT-
PCR analysis of BIO-induced MM cells in which levels of epithelial
markers Lim-1 and E-cadherin were unaltered with CT-HC-1 treat-
ment (Fig. 4I). Furthermore, in cells exposed only to CT-HC-1 and not
an inductive ligand, peptide treatment caused a decrease in Axin-2
expression, as expected, but it also enhanced expression of Lim-1 and
E-cadherin (Fig. 4J). This observation is consistent with recent reports
describing an antagonistic relationship between canonical and non-
canonical Wnt mechanisms (Park et al., 2007; Schmidt-Ott et al.,
2007).
Fig. 3.Wnt4 does not induce canonical Wnt signaling. A. Effects of Wnt recombinant proteins on TOPﬂash activity. TOPﬂash reporter constructs were transfected into primary MM
cells using an Amaxa Nucleofector system. Twenty-four hours after transfection, cells were treated withWnt recombinant proteins (100 ng/ml) or Wnt3aCM (10%) and cultured for
an additional 24 h. Luciferase activities were measured by a dual reporter assay system and normalized by renilla activity. B. Axin2 expression byWnt recombinant proteins. Primary
MM cells were cultured on 6-well plates and treated with recombinant Wnt4 or Wnt3a protein (100 ng/ml) for 24 h, and then harvested with TRIZOL. cDNAs were synthesized and
analyzed by semi-quantitative RT-PCR with Axin2 and GAPDH primers. C. and D. Effects of Wnt recombinant proteins on Wnt activated proteins. Primary MM cells were plated and
then treated 24 h later with Wnt4 (C) or Wnt3a (D) recombinant proteins (100 ng/ml) for the time interval indicated. Cells were harvested with SDS sample buffer and analyzed by
Immunoblotting with the indicated antibody.
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following CT-HC-1 treatment, we asked whether inhibition of β-
catenin is sufﬁcient to induce tubulogenesis in MMs. Despite repeated
attempts, therewas no consistent evidence to support this hypothesis.
MMs showed condensation with minimal evidence of tubule
formation (data not shown). Since we have previously demonstrated
that FGF2 (Karavanov et al., 1998), which is required to maintain MM
cells, is sufﬁcient to weakly induce tubules, we were unable to
distinguish between the effects of the growth factor and our inhibitor.
Regardless, the response did not resemble the robust production of
tubules elicited with Wnt4 treatment.
Wnt4 activates CaMKII by inducing Ca2+ inﬂux
Since Wnt4 had little effect on the canonical Wnt pathway in MM
cells, we asked whether Wnt4-induced differentiation was due to the
activation of a non-canonical Wnt mechanism. To address the
possibility of a non-canonical Wnt mechanism, we evaluated the
activity of CaMKII, a target of intracellular Ca2+ ﬂux, by immuno-
blotting with an anti-phospho CaMKII antibody. Like calcium
ionophores, Ionomycin and A23187, Wnt4 induced a rapid (60 s)
phosphorylation of CaMKII (Figs. 5A and B). When these cells were
instead pretreated with Ca2+ chelator BAPTA-AM, Wnt4 failed to
induce phosphorylation of CaMKII (Fig. 5C), indicating that Wnt4
activates CaMKII by stimulating Ca2+ inﬂux in MM cells. To conﬁrm
whether Wnt4 directly induces Ca2+ inﬂux in MM cells, Wnt4-mediated Ca2+ inﬂux was examined using the Ca2+ indicator Fluo-
4NW. As shown in Fig. 5D, Ca2+ inﬂux occurred in 1 min following
Wnt4 treatment and in a dose-dependent manner. A signiﬁcant
difference between control and Wnt4 treatment was observed at a
range of Wnt4 treatments (100–500 ng/ml; Fig. 5E). These results
indicate that Wnt4 stimulates a rapid Ca2+ inﬂux in MM cells at
levels that induce tubule formation.Ca2+ inﬂux induces tubule formation
To conﬁrm that Ca2+ inﬂux is sufﬁcient to induce tubule
formation, MMs were treated with 10 nM Ionomycin and cultured
for 3 days. Tubular morphogenesis was readily apparent in Ionomy-
cin-treated MMs by microscopy (Fig. 6A). Ionomycin-induced MET
was also demonstrated by up regulation of differentiation markers
Lim1, E-cadherin, ZO-1, occludin, Pax8, and Pax2 (Fig. 6B). These results
suggest that intracellular Ca2+ inﬂux is sufﬁcient to induce tubule
formation. We also examined the effect of Ca2+ inﬂux on stabilization
of β-catenin in primary MM cells treated with Ionomycin for 24 h. As
shown in Supplementary Fig. 3, there was no signiﬁcant increase in
levels of β-catenin following Ionomycin treatment, whereas Wnt3a
stabilized β-catenin under these conditions. These data support the
hypothesis that Wnt4, through the stimulation of calcium inﬂux,
induces MM progenitors to undergo MET independent of canonical
Wnt signaling.
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Genetic studies have revealed an essential role forWnt signaling in
mesenchymal–epithelial transition (MET) during nephron formation.There is evidence that β-catenin is necessary for epithelial differen-
tiation although the precise molecular mechanism is not yet clear. In
the current study, we have found that Wnt4-mediated tubulogenesis
inmetanephric mesenchyme occurs by a non-canonicalWnt/calcium-
Fig. 4. Dominant-negative inhibitor of β-catenin, CT-HC-1, blocks canonical Wnt signaling by inducing β-catenin degradation. A. Helix C (highlighted in blue) interacts with the
armadillo repeat domain of β-catenin. B. Structural analogs of helix C and the intracellular domain of EpCAM that were tested for Wnt-associated biological activity. C. CT-HCs are
potent inhibitors of β-catenin stabilization. Primary MM cells were treated with CT-HCs (10 μM) for 24 h. Cells were harvested with SDS sample buffer and analyzed by
immunoblotting with β-catenin or β-actin antibodies. CT-HC-3 and -5 are highly cytotoxic and were not used in subsequent studies. D and E. CT-HC-1 blocks TCF-dependent
transcription. TOPﬂash reporter constructs were transfected into primary MM cells, using an Amaxa Nucleofector system. Twenty-four hours after transfection, MM cells were pre-
treated with or without CT-HC-1 (10 μM) for 30 min, and then exposed to BIO (500 nM) (D) or Wnt3a CM (50%) (E) for 24 h. Luciferase activities were measured by a Dual reporter
assay system andnormalized by renilla activity. Each value represents themean±SD of three or four separate experiments. **pb0.01 vs control. F andG. CT-HC-1 stimulatesβ-catenin
protein degradation by a proteasome-dependentmechanism. PrimaryMMcells were pre-treatedwith orwithoutMG132 (5 μM) for 30 min, and then exposed to CT-HC-1 (10 μM) for
3 h. Cells were harvestedwith SDS sample buffer and analyzed by immunoblottingwithβ-catenin orβ-actin antibodies. EpCAM-1 peptide served as a negative control. H. Inhibition of
β-catenin fails to abrogate tubule formation. Expanded primary MM cells were trypsinized, co-cultivated with embryonic spinal cord on collagen type IV-treated ﬁlter, and then
treatedwith CT-HC-1 (10 μM) or negative control peptide (10 μM) for 6 days. Tissues were ﬁxedwith 4% PFA and evaluated byWISH using a Lim1 riboprobe. I. CT-HC-1 does not block
BIO-induced Lim1 and E-cadherin expression. PrimaryMM cells were pre-treated with or without BIO (500 nM) for 30 min, and then exposed to CT-HC-1 (10 μM) for 24 h. Cells were
harvested with TRIZOL. cDNAs were synthesized and assessed by semi-quantitative RT-PCR with Axin2 and GAPDH primers. J. CT-HC-1 induces Lim1 and E-cadherin expression.
Primary MM cells were treated with CT-HC-1 (10 μM) for 24 h, and then harvested with TRIZOL. cDNA was manipulated as in I.
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transcription dependent mechanism. An analysis of a BATlacZ
reporter mouse suggested that TCF-dependent transcription is
activated in the branching UB, but not in MM. However, recombinant
Wnt4 protein could induce tubulogenesis without activation of the
canonical Wnt pathway. This was demonstrated by an inability of
recombinant Wnt4 protein to activate a TCF reporter, induce the
expression of canonical Wnt pathway target gene Axin-2, or stabilize
β-catenin in MM cells. Moreover, the novel dominant-negative
inhibitor for β-catenin CT-HC-1 abrogated canonical Wnt signaling
yet failed to inhibit tubulogenesis. These results by exclusion then
suggest that Wnt4 induces nephrogenesis through a non-canonical
Wnt mechanism. In our studies, we have found that a calcium-
dependent pathway is activated by Wnt4 and is involved in
tubulogenesis. Calcium-dependent activities, including calcium inﬂux
and CaMKII phosphorylation, were observed in MM cells in responseto Wnt4 treatment. Interestingly, the calcium ionophore Ionomycin
induced tubule formation, suggesting that calcium inﬂux in MM is
sufﬁcient to cause tubule formation.
A number of laboratories have found little reporter activity in MMs
and renal vesicles in transgenic mice expressing a TCF-driven β-
galactosidase reporter (Iglesias et al., 2007; Maretto et al., 2003;
Schmidt-Ott et al., 2007; Schwab et al., 2007). It has been suggested
that the absence of activity may be due to the insensitivity of the
reporter transgene (Barolo, 2006). It is also conceivable that the TCF-
driven constructs are not expressed in MMs because of the lack of
certain components required for expression in speciﬁc cellular
environments. We show in the present study that β-galactosidase
activity can be detected in MMs from BATlacZ transgenic mice when
exposed to BIO or WA, indicating that the construct is active in MMs
(Supplementary Fig. 1). Interestingly, two of these articles report that
β-gal activity can also be detected in S-shaped bodies, i.e., polarized
66 S. Tanigawa et al. / Developmental Biology 352 (2011) 58–69epithelial structures (Iglesias et al., 2007; Schmidt-Ott et al., 2007),
suggesting that TCF-dependent transcription is active after the
establishment of epithelial polarity. Unfortunately, no effort was
made to rule out possible staining from the fused tip of the UB in
tissue sections. Park et al. (2007) showed that in β-catenin GOF
mutants crossed with a conditional β-galactosidase reporter allele
(R26R), β-gal positive cells condense but are E-cadherin negative and
do not form tubules, indicating that MET is blocked in MMs when
stabilized β-catenin is present continuously (Park et al., 2007).
Similarly, MMs with stabilized β-catenin proliferate, aggregate, andFig. 6. Ionomycin induces tubule formation in MMs. A. Induction of tubule formation by
Ionomycin. Isolated MMs were cultured on collagen type IV-coated ﬁlters and then
treated with 10 nM Ionomycin. After 24 h of treatment, Ionomycin was removed and
mesenchymes were cultured in the medium up to 3 days. B. Ionomycin induces
expression of differentiation markers. Ionomycin-treated MM was harvested with
TRIZOL at 3 days, and expression of Lim1, E-cadherin, ZO-1, Occludin, Pax2, Pax8 and
GAPDH were analyzed by RT-PCR as described above.escape apoptosis, but cannot complete epithelial conversion (Park et
al., 2007; Schmidt-Ott et al., 2007). In light of this, our data support
the notion that a β-catenin/TCF-independent mechanism, such as
Wnt-induced Ca2+ inﬂux, is required for MET and tubule formation in
MM progenitors, and that the role of transcription-dependent Wnt/β-
catenin signaling may be limited to the survival and proliferation of
cells in the MM. Furthermore, they suggest that β-catenin signaling
must become attenuated before MET can occur.
In efforts to regulate Wnt transcriptional activation, we designed
and evaluated peptides that target different canonicalWnt regulators:
one involving the intracellular domain of EpCAM, which interacts
with β-catenin to activate transcription, and the other helix C in β-
catenin, a hydrophobic region that caps the 12th armadillo repeat in
β-catenin and is essential for transcriptional activation but not cell
adhesion. Peptides designed to target EpCAM yielded no reduction in
transcriptional activation, so these peptides were used as negative
controls in subsequent studies. On the other hand, helix C peptides
exhibited a striking inhibition of transcription. One of these peptides
CT-HC-1 showed little toxicity and also apparently facilitatedFig. 5. Wnt4 activates a Ca2+-dependent pathway. A. Wnt4 induces CaMKII
phosphorylation. Primary MM cells were treated with Wnt4 recombinant protein
(100 ng/ml) for the indicated times, harvested with SDS sample buffer, and analyzed by
immunoblotting with CaMKII antibodies. B. CaMKII phosphorylation is induced by Ca2+
ionophores in MM cells. Primary MM cells were treated with ionophores (10–100 nM)
for 1 min, harvested with SDS sample buffer, and analyzed by immunoblotting with
CaMKII antibodies. C. Ca2+ chelator, BAPTA-AM blocks Wnt4-induced phosphorylation
of CaMKII. Primary MM cells were treated with Ca2+ chelator BAPTA-AM (10 μM) for
15 min, and then with Wnt4 (100 ng/ml) for 1 min. Cells were harvested with SDS
sample buffer and analyzed by immunoblotting with CaMKII antibodies. D. Wnt4
induces Ca2+ inﬂux. Primary MM cells were cultured in black, clear-bottom 96 well
plate. Twenty-four hours after seeding, cells were incubated with Fluo-4NW for 30 min
and then treated with Wnt4. Recombinant Wnt4 was added at indicated concentra-
tions, and intracellular calcium ﬂux was measured by ﬂuorescence plate reader every
1 s for 240 s. Background ﬂuorescence for each well was measured, and the average
background was subtracted from each value. Relative ﬂuorescence units were obtained
using a ﬂuorescence plate reader and background was subtracted from each value. Data
are representative of 3–5 independent experiments. The graph represents the mean±
S.D. (n=3). Each value represents the *pb0.05 vs control (E).
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markers. This peptide appeared to function by inducing proteasomal
degradation of β-catenin (Fig. 4F), since β-catenin levels were
restored in the presence of proteasomal inhibitor MG132. This
observation is consistent with a previous report that the C-terminal
domain of β-catenin (CTD) interferes with its binding to Axin and APC
(Choi et al., 2006) and that the CTD facilitates the accumulation of
β-catenin by shielding the armadillo repeat domain from the Axin-
scaffold phospho-destruction complex (Mo et al., 2009). Therefore,
CT-HC-1 may cause a conformational change in β-catenin, thus
allowing the formation of a destruction complex, including Axin and
APC, on the armadillo repeat domain of β-catenin.
There is general agreement that the development of reagents that
target the Wnt pathway is a worthwhile endeavor, considering its
established role in human neoplasms, such as the pediatric renal
cancer calledWilms tumor, and its involvement and interactions with
a wide variety of signaling pathways. Ideally, such small molecules
would permit the investigation of those interactions as well as
potentially provide more effective chemotherapies for tumors that
depend upon canonical Wnt signaling. A number of small molecules
that target canonical Wnt/β-catenin signaling components have been
identiﬁed (Chen et al., 2010). Most affect components of the canonical
Wnt/β-catenin pathway, including Axin (Chen et al., 2009; Huang et
al., 2009), CK2 (Gao and Wang, 2006), or the TCF/β-catenin complex
(Gandhirajan et al., 2010). Recently identiﬁed XAV939 antagonizes
the canonical Wnt pathway by inducing β-catenin degradation in
SW480 cells; however, this is accomplished by ﬁrst stabilizing Axin
through inhibition of tankyrase, which, in turn, stimulates β-catenin
degradation (Huang et al., 2009). In a cell-based screen of some
63,000 small molecule inhibitors, Ewan et al. identiﬁed a compound,
which blocked TCF-dependent transcription without affecting the
degradation of β-catenin in some cell lines, suggesting that the
compound acts independently of β-catenin levels (Ewan et al., 2010).
In another large screen forWnt antagonists an evaluation of ~200,000
compounds in a library yielded nine compounds that were distributed
in two functional groups—those that blocked ligand production and
those that blocked ligand signaling (Chen et al., 2009). The former
include compounds that inhibit porcupine, an O-acyltransferase that
adds a palmitoyl group to Wnts for secretion and signaling. The latter
are thought to inhibit canonical Wnt signaling by direct interaction
with Axin-2 to stimulate β-catenin degradation. Thus far, inhibitors
discovered in screening do not directly target β-catenin, perhaps due
to its critical membrane interaction with E-cadherin complexes in
adherens junctions. Our C helix inhibitor appears not to disrupt
junctional complexes, since tubulogenesis occurs normally, yet it
completely blocked canonical Wnt signaling at levels which were not
toxic to these progenitors. This peptide then may serve as an effective
tool for dissecting canonical from noncanonical mechanisms and may
have efﬁcacy against tumor cells that depend upon canonical Wnt
signaling, but further study is needed. Furthermore, the design of such
structure-based cell permeable peptides for β-catenin may provide a
useful alternative approach for the discovery of molecules that target
speciﬁc Wnt-dependent processes, in lieu of costly high-throughput
screening methods.
Previous studies have revealed a role for theWnt/calcium pathway
in zebraﬁsh and Xenopus embryos. Overexpression of Wnt5a can
trigger intracellular Ca2+ inﬂux, leading to the activation of Ca2+-
dependent effector molecules such as CaMKII (Kuhl et al., 2000a;
Moon and Shah, 2002). It has been proposed that active CaMKII
protein can then initiate a protein kinase signaling cascade, resulting
in NLK-mediated phosphorylation of TCF/LEF transcription factors.
This phosphorylation of TCF/LEF prevents the β-catenin–TCF/LEF
transcriptional complex from binding to DNA (Ishitani et al., 2003,
1999). In this model, inhibition of Wnt/β-catenin signaling due to
Wnt5a-stimulated Ca2+ inﬂux occurs downstream of β-catenin
stabilization and at the level of TCF-mediated transcription. Basedon these ﬁndings, our data suggest that Wnt4 might induce a Ca2+-
mediated phosphorylation of CaMKII, and, thus, in turn, terminate
canonicalWnt signaling in nephrogenesis. Additionally, since snail is a
target of canonical Wnt signaling and since it inhibits E-cadherin
expression (Batlle et al., 2000; Cano et al., 2000; Nieto, 2002), a Wnt4-
induced attenuation of the canonical Wnt pathway may be sufﬁcient
to induce E-cadherin expression and facilitate MM morphogenesis.
Alternatively, an increase of intracellular Ca2+ leads to activation
of a calcineurin-dependent pathway including the transcription factor
Nuclear Factor of Activated T cells (NFAT), which is activated in most
immune system cells to stimulate cytokine transcription and is
involved in the development and morphogenesis of a variety of
vertebrate tissues (Medyouf and Ghysdael, 2008). In unstimulated
cells, NFATc transcription factors are highly phosphorylated and
sequestered to the cytoplasm. When a stimulus results in an increase
in intracellular Ca2+, the heterodimeric serine/threonine phosphatase
calcineurin dephosphorylates NFATc, resulting in an allosteric switch
that exposes a nuclear localization sequence and conceals a nuclear
export sequence. NFATc then translocates to the nucleus and binds to
speciﬁc regions in the promoters of target genes. The activity of NFAT
proteins is tightly regulated by the calcium/calmodulin-dependent
phosphatase calcineurin, a primary target for inhibition by cyclospor-
ine A (CSA) and FK506 (Beals et al., 1997a). The nuclear import and
activation of NFATc are opposed by rephosphorylation of NFATc by
GSK3 (Beals et al., 1997b) or CKI (Okamura et al., 2004). The role of a
calcineurin-dependent pathway in developing kidney has been
suggested using CSA in mouse embryonic kidney. Treatment of
mouse embryonic kidneys with CSA inhibits proliferation in embry-
onic kidneys in culture (Alcalay et al., 2007). Furthermore, calcineurin
A knockout mice display renal hypoplasia and postnatal lethality
(Gooch et al., 2004). Inhibition of calcineurin with CSA treatment in
rat embryonic kidneys reduced nephron formation, suggesting that
a calcineurin-dependent pathway is involved in nephrogenesis
(Merlet-Bénichou et al., 1996). In addition, dominant-negative NFAT
inhibits canonical Wnt signaling by suppressing β-catenin expression
in Xenopus (Saneyoshi et al., 2002). In our study, we have noted that
Wnt4 activates an NFAT-dependent promoter as does Ionomycin
treatment in primary MM cells (Supplementary Fig. 4). Burn et al. (in
press) have also found that a non-canonical calcium/NFAT pathway
functions downstream of Wnt4 in nephrogenesis. In these studies,
they demonstrate that all ﬁve NFAT family members are expressed in
the developing mouse metanephros and that inhibition of calcium/
NFAT signaling reduces nephron formation. Furthermore, they were
able to rescue nephron formation inWnt4−/−metanephroi with the
calcium ionophore Ionomycin. Therefore, aWnt4-induced Ca2+ inﬂux
may trigger the calcineurin/NFAT pathway; however, the role of this
pathway on tubule formation is not yet clear. Calcineurin depho-
sphorylates not only NFAT, but also Cux-1, which is highly expressed
in the nephrogenic zone of the developing kidney (Vanden Heuvel et
al., 1996) and functions as a transcriptional repressor of the cyclin
kinase inhibitors p21 and p27 (Coqueret et al., 1998; Ledford et al.,
2002). Ectopic expression of Cux-1 in transgenic mice causes renal
hyperplasia (Ledford et al., 2002). Therefore, the calcineurin-depen-
dent pathway may function as a general regulator of cell proliferation
during tubule formation. In our study, we have revealed that Ca2+
inﬂux in MM is sufﬁcient to induce tubule formation. However, the
precise downstream targets of calcium-dependent signaling, includ-
ing CaMKII and calcineurin still remain undeﬁned and future studies
are required to elucidate their roles.
In summary, our work provides a better understanding of the
mechanism of MET in MM, implicating the non-canonical Wnt/
calcium pathway. Particularly, Wnt4-induced Ca2+ inﬂux plays a
crucial role in tubulogenesis, and such observations contribute to our
understanding of the mechanism and potential connection between
canonical Wnt and non-canonical Wnt signaling during early kidney
development.
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